Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
03 2022
Historique:
revised: 07 11 2021
received: 07 07 2021
accepted: 13 11 2021
pubmed: 25 11 2021
medline: 12 4 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

Anastomotic leakage after restorative surgery for rectal cancer shows high morbidity and related mortality. Identification of risk factors could change operative planning, with indications for stoma construction. This retrospective multicentre study aims to assess the anastomotic leak rate, identify the independent risk factors and develop a clinical prediction model to calculate the probability of leakage. The study used data from 24 Italian referral centres of the Colorectal Cancer Network of the Italian Society of Surgical Oncology. Patients were classified into two groups, AL (anastomotic leak) or NoAL (no anastomotic leak). The effect of patient-, disease-, treatment- and postoperative outcome-related factors on anastomotic leak after univariable and multivariable analysis was measured. A total of 5398 patients were included, 552 in group AL and 4846 in group NoAL. The overall incidence of leaks was 10.2%, with a mean time interval of 6.8 days. The 30-day leak-related mortality was 2.6%. Sex, body mass index, tumour location, type of approach, number of cartridges employed, weight loss, clinical T stage and combined multiorgan resection were identified as independent risk factors. The stoma did not reduce the leak rate but significantly decreased leak severity and reoperation rate. A nomogram with a risk score (RALAR score) was developed to predict anastomotic leak risk at the end of resection. While a defunctioning stoma did not affect the leak risk, it significantly reduced its severity. Surgeons should recognize independent risk factors for leaks at the end of rectal resection and could calculate a risk score to select high-risk patients eligible for protective stoma construction.

Identifiants

pubmed: 34816571
doi: 10.1111/codi.15997
pmc: PMC9300066
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-276

Investigateurs

Francesco Evola (F)
Michela Mineccia (M)
Francesca Pecchini (F)
Gaetano Gallo (G)
Paola Incollingo (P)
Fabio Maiello (F)
Andrea Barberis (A)
Monica Ortenzi (M)
Vittoria Bellato (V)
Caterina Foppa (C)
Vincenzo Adamo (V)
Cristina Bombardini (C)
Alessandro Giuliani (A)
Francesca Cravero (F)
Marco Amisano (M)
Pietro Paolo Bianchi (PP)
Gabriele Anania (G)
Marco Calgaro (M)
Antonino Spinelli (A)
Giuseppe S Sica (GS)
Marito Guerrieri (M)
Marco Filauro (M)
Roberto Polastri (R)
Francesco Bianco (F)
Giuseppe Sammarco (G)
Micaela Piccoli (M)
Alessandro Ferrero (A)
Domenico D'Ugo (D)

Informations de copyright

© 2021 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Références

Colorectal Dis. 2014 Aug;16(8):603-9
pubmed: 24750995
Ann Surg. 2019 Apr;269(4):589-595
pubmed: 30080730
Ann Surg. 2007 Feb;245(2):254-8
pubmed: 17245179
Ann Surg. 2015 Dec;262(6):e111
pubmed: 24950267
N Engl J Med. 2015 Apr 2;372(14):1324-32
pubmed: 25830422
Ann Surg. 2013 Apr;257(4):665-71
pubmed: 23333881
Tech Coloproctol. 2019 Jul;23(7):649-663
pubmed: 31240416
Surg Endosc. 2012 Nov;26(11):3330-3
pubmed: 22580885
World J Surg. 2010 May;34(5):1080-5
pubmed: 20145926
Br J Surg. 2001 Sep;88(9):1157-68
pubmed: 11531861
Ann Surg Oncol. 2011 Oct;18(10):2772-82
pubmed: 21468782
J Am Coll Surg. 2009 Dec;209(6):694-701
pubmed: 19959036
J Am Coll Surg. 2009 Feb;208(2):269-78
pubmed: 19228539
Ann Surg. 1973 May;177(5):513-8
pubmed: 4540874
Br J Surg. 2003 May;90(5):583-92
pubmed: 12734867
Dis Colon Rectum. 1983 Feb;26(2):87-90
pubmed: 6822175
Colorectal Dis. 2007 Jan;9(1):71-9
pubmed: 17181849
Surg Endosc. 2010 May;24(5):1205-10
pubmed: 20186432
Ann Surg. 2014 May;259(5):930-8
pubmed: 24045445
Ann Surg. 2017 Mar;265(3):474-480
pubmed: 27631776
Tech Coloproctol. 2008 Jun;12(2):103-10
pubmed: 18545882
Int J Colorectal Dis. 2018 Apr;33(4):411-418
pubmed: 29411120
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Surg Endosc. 2009 Jun;23(6):1379-83
pubmed: 19037698
Int J Colorectal Dis. 2008 Jul;23(7):703-7
pubmed: 18379795
JAMA. 2015 Oct 6;314(13):1356-63
pubmed: 26441180
Lancet Oncol. 2014 Jun;15(7):767-74
pubmed: 24837215
Br J Surg. 1998 Mar;85(3):355-8
pubmed: 9529492
JAMA. 2015 Oct 6;314(13):1346-55
pubmed: 26441179
Br J Surg. 2002 Aug;89(8):1008-13
pubmed: 12153626
World J Surg. 2008 Jun;32(6):1147-56
pubmed: 18283511
Ann Surg Treat Res. 2014 Apr;86(4):206-11
pubmed: 24783180
Br J Surg. 1999 Jul;86(7):927-31
pubmed: 10417567
Colorectal Dis. 2022 Mar;24(3):264-276
pubmed: 34816571
Int J Colorectal Dis. 2017 Nov;32(11):1531-1538
pubmed: 28840326
Surgery. 2010 Mar;147(3):339-51
pubmed: 20004450
J Am Coll Surg. 1997 Aug;185(2):105-13
pubmed: 9249076
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003144
pubmed: 22336786
J Clin Oncol. 2002 Feb 1;20(3):817-25
pubmed: 11821466
Cancer. 1994 Jun 1;73(11):2680-6
pubmed: 8194005
Dis Colon Rectum. 2020 Jan;63(1):93-100
pubmed: 31804271
Arch Surg. 2003 Dec;138(12):1334-8; discussion 1339
pubmed: 14662534
Tech Coloproctol. 2021 Feb;25(2):245-246
pubmed: 33011898

Auteurs

Maurizio Degiuli (M)

Division of Surgical Oncology and Digestive Surgery, Department of Oncology, San Luigi University Hospital, University of Turin, Turin, Italy.

Ugo Elmore (U)

Division of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.

Raffaele De Luca (R)

Department of Surgical Oncology, IRCCS Istituto Tumori 'G. Paolo II', Bari, Italy.

Paola De Nardi (P)

Division of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.

Mariano Tomatis (M)

Department of Oncology, University of Turin, Turin, Italy.

Alberto Biondi (A)

Fondazione Policlinico Gemelli-IRCCS, AREA di Chirurgia Addominale, Rome, Italy.

Roberto Persiani (R)

Fondazione Policlinico Gemelli-IRCCS, AREA di Chirurgia Addominale, Rome, Italy.

Leonardo Solaini (L)

General and Oncologic Surgery, Morgagni-Pierantoni Hospital, Ausl Romagna, Forlì, Italy.

Gianluca Rizzo (G)

Fondazione Policlinico Universitario A. Gemelli-IRCCS, Chirurgia Generale Presidio Columbus, Rome, Italy.

Domenico Soriero (D)

Surgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.

Desiree Cianflocca (D)

Department of Surgery, S. Croce e Carle Hospital, Cuneo, Italy.

Marco Milone (M)

Department of Clinical Medicine and Surgery, Department of Gastroenterology, Endocrinology and Endoscopic Surgery, University of Naples 'Federico II', Naples, Italy.

Giulia Turri (G)

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Verona, Italy.

Daniela Rega (D)

Colorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.

Paolo Delrio (P)

Colorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.

Corrado Pedrazzani (C)

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Verona, Italy.

Giovanni D De Palma (GD)

Department of Clinical Medicine and Surgery, Department of Gastroenterology, Endocrinology and Endoscopic Surgery, University of Naples 'Federico II', Naples, Italy.

Felice Borghi (F)

Department of Surgery, S. Croce e Carle Hospital, Cuneo, Italy.

Stefano Scabini (S)

Surgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.

Claudio Coco (C)

Fondazione Policlinico Universitario A. Gemelli-IRCCS, Chirurgia Generale Presidio Columbus, Università Cattolica del Sacro Cuore, Rome, Italy.

Davide Cavaliere (D)

General and Oncologic Surgery, Morgagni-Pierantoni Hospital, Ausl Romagna, Forlì, Italy.

Michele Simone (M)

Department of Surgical Oncology, IRCCS Istituto Tumori 'G. Paolo II', Bari, Italy.

Riccardo Rosati (R)

Division of Gastrointestinal Surgery, San Raffaele Hospital, Vita Salute University, Milan, Italy.

Rossella Reddavid (R)

Division of Surgical Oncology and Digestive Surgery, Department of Oncology, San Luigi University Hospital, University of Turin, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH